Why is Venmax Drugs falling/rising?

As of 23-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 23.85, which reflects a decrease of Rs 1.25 or 4.98%. The stock has underperformed its sector by 4.63% today and has been on a downward trend, falling consecutively for the last two days with a total decline of 9.66%. It opened the day with a loss of 4.78% and reached an intraday low of Rs 23.85. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Notably, investor participation has significantly decreased, with delivery volume dropping by 97.38% compared to the 5-day average, suggesting a lack of confidence among investors.
In the broader market context, Venmax Drugs has underperformed relative to the Sensex, with a 1-week return of -3.71% compared to the benchmark's -0.34%. Over the past month, the stock has seen a substantial decline of 24.53%, while the Sensex has gained 0.98%. Year-to-date, however, Venmax Drugs shows a positive return of 32.21%, significantly outperforming the Sensex's 5.07%. This indicates that while the stock has had a strong performance earlier in the year, recent trends suggest a shift in market sentiment that is negatively impacting its price.